Delivery Order SPE2DR25D2104-SPE2DR26F3TMM
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $6,332.08 to AmerisourceBergen Drug Corp for the supply of CIBINQO 100 mg tablets (30-count units) on January 13, 2026, with an ultimate completion date of January 14, 2026. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,818.27 to AmerisourceBergen Drug Corp for CIBINQO 100 mg tablets (30-count units) on November 14, 2025, with an ultimate completion date of November 17, 2025. This competitive award, which carries no set-aside designation, is structured as a firm fixed price delivery order and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $13,362.26 to AmerisourceBergen Drug Corp for 30-count bottles of CIBINQO 100 MG tablets, with completion expected by December 11, 2025. This non-set-aside, firm fixed-price delivery order was issued under a competitive procurement process and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Cibinqo 100 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $7,742.67 and an ultimate completion date of June 2, 2025. The contract was competitively awarded with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,818.27 to AmerisourceBergen Drug Corp for 30-count bottles of Cibinqo 100 mg tablets, a pharmaceutical product to be delivered to the vendor's corporate office location in Conshohocken, Pennsylvania. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of December 15, 2025. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,228.69 to AmerisourceBergen Drug Corp for the supply of Cibinqo 100 mg tablets in quantities of 30. The award, issued on December 18, 2025, represents a firm fixed price delivery order with an ultimate completion date of December 19, 2025. This non-competitive delivery order draws from AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a maximum...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a competitively procured delivery order valued at $6,942.36 by the Defense Logistics Agency's Medical Supply Chain on January 12, 2026, with an ultimate completion date of January 13, 2026. This firm fixed-price delivery order carries no set-aside designation and represents a continuation of the company's extensive pharmaceutical supply relationship with the Department of Defense. The award is issued under...
- On January 13, 2026, the Defense Logistics Agency awarded a delivery order valued at $10,914.63 to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The firm fixed-price contract, designated 4570500085, carries no set-aside designation and represents a competitive award to support pharmaceutical procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $166,166.63 on January 12, 2026, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price, non-set-aside delivery order is scheduled for ultimate completion on January 13, 2026, with performance to be executed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a task order issued under a larger Indefinite Delivery Contract...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $5,375.10 to AmerisourceBergen Drug Corp (CAGE 0U9U0), a subsidiary of parent company Cencora, Inc., on January 9, 2026, with an ultimate completion date of January 12, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at the awardee's corporate office in Conshohocken, Pennsylvania. The delivery order represents a task order issued...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3TMMDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,357.65 to AmerisourceBergen Drug Corp for the supply of CIBINQO 100 mg tablets in quantities of 30 units. This firm fixed-price delivery order, issued on January 13, 2026, with an ultimate completion date of January 14, 2026, represents a non-competitive award under an existing contract vehicle. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc., a major pharmaceutical distribution and healthcare solutions provider serving federal government agencies. This delivery order is executed under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999.99 million through December 2026. This comprehensive IDC serves as the primary vehicle for supplying a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including medications across multiple therapeutic domains, vaccines, syringes, and other critical medical commodities. The contract supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. As an open and fully competitive contract holder, AmerisourceBergen has demonstrated the capability to efficiently fulfill federal pharmaceutical procurement requirements across diverse medical supply needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.4k | 1/12/26 |